Quantum Cyber is a high-stakes reincarnation from failed diagnostics micro-cap into a speculative quantum-secure autonomous defense platform.
Overview
Quantum Cyber N.V. is a radical micro-cap reinvention: formerly Mainz Biomed, it has abandoned molecular diagnostics to pursue quantum-safe cybersecurity, autonomous drones, and counter-UAS defense. New leadership under David Lazar and Robert Liscouski is targeting U.S. defense, sovereign governments, and Global 2000 security buyers. Current revenue remains legacy diagnostics, but the future model aims to combine drone hardware with recurring Quantum-Safe-as-a-Service subscriptions. The opportunity is large, but the company is effectively pre-revenue in defense and highly speculative.